Medgensys Laboratories Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.10 M
- Company Age 18 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 7.82 M
- Revenue Growth -95.33%
- Profit Growth -83.58%
- Ebitda -92.47%
- Net Worth 3.44%
- Total Assets -6.05%
About Medgensys Laboratories
Medgensys Laboratories Private Limited (MLPL) is a Private Limited Indian Non-Government Company incorporated in India on 04 December 2006 and has a history of 18 years and two months. Its registered office is in Delhi, India.
The Corporate was formerly known as Medgensys Chempharm (India) Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹7.82 M.
Archana Maggu and Vijender Kumar serve as directors at the Company.
Company Details
-
Location
Delhi, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24110DL2006PTC156151
-
Company No.
156151
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
04 Dec 2006
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Medgensys Laboratories?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Archana Maggu
|
Director | 15-May-2015 | Current |
|
Vijender Kumar
|
Director | 04-Jul-2022 | Current |
Financial Performance of Medgensys Laboratories.
Medgensys Laboratories Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 95.33% decrease. The company also saw a substantial fall in profitability, with a 83.58% decrease in profit. The company's net worth moved up by a moderate rise of 3.44%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Medgensys Laboratories?
Unlock access to Medgensys Laboratories's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Pleasantville Investments Private LimitedArchana Maggu is a mutual person
Charges (Loans)
₹7.82 M
₹0
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 0.78 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 15 Dec 2020 | Hdfc Bank Limited | ₹7.82 M | Open |
How Many Employees Work at Medgensys Laboratories?
Unlock and access historical data on people associated with Medgensys Laboratories, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Medgensys Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medgensys Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
